Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

Post by Jennifer2020on Aug 07, 2021 1:48pm
275 Views
Post# 33668504

Remote training and installation

Remote training and installationI expect the "good news" alluded to in the mgmt email about the AGM is sales.  This is the email that got things rolling from the low of .295

In fact, the company has already gained early sales traction with 16 sites completed the placements and 11 sites in progress. The Hospital committed placements breakdown is as per follows:

  • Canada – 5 sites completed/2 additional sites in process
  • US – 1 site completed/4 additional sites in process
  • UK – 1 site completed and 3 sites in process
  • Europe – 1 site completed/2 sites in process
  • China – 8 sites completed

Last but not least, it is anticipated that multiple units will be purchased regularly by each hospital that uses the VMS+3.0 system – further boosting the growth ahead.

https://www.smallcapasia.com/5-things-to-like-about-ventripoint/


<< Previous
Bullboard Posts
Next >>